.
This commit is contained in:
@@ -1,340 +0,0 @@
|
||||
---
|
||||
title: "Normal Aging Brain"
|
||||
docid: "2a315550-b2ea-4afe-a2ef-f93a2209f276"
|
||||
breadcrumbs:
|
||||
- "Brain"
|
||||
- "Diagnosis"
|
||||
- "Pathology-Based Diagnoses"
|
||||
- "Acquired Toxic/Metabolic/Degenerative Disorders"
|
||||
- "Dementias and Degenerative Disorders"
|
||||
- "Normal Aging Brain"
|
||||
---
|
||||
# KEY FACTS
|
||||
|
||||
- ## Terminology
|
||||
|
||||
|
||||
- ↓ overall brain volume with advancing age
|
||||
- Reflected in relative ↑ CSF spaces
|
||||
- ## Imaging
|
||||
|
||||
|
||||
- Broad spectrum of "normal" on imaging in elderly
|
||||
- "Successfully aging brain"
|
||||
- Smooth, thin, periventricular, high signal rim on FLAIR is normal
|
||||
- White matter hyperintensities (WMHs) absent/few
|
||||
- ↓ total brain volume
|
||||
- Selective atrophy of white matter (not gray matter) predominates
|
||||
- ± punctate hippocampal Ca⁺⁺
|
||||
- Enlarged perivascular (Virchow-Robin) spaces
|
||||
- WMHs ↑ in number/size after 50 years
|
||||
- Focal high signal intensity in splenium of corpus callosum
|
||||
- GRE/SWI
|
||||
- Increasing mineralization of basal ganglia with age
|
||||
- "Black line" in visual, motor/sensory cortex
|
||||
- Microbleeds are relatively common in aging patients
|
||||
- Lower prevalence than in cerebral amyloid disease & Alzheimer disease
|
||||
- ## Top Differential Diagnoses
|
||||
|
||||
|
||||
- Mild cognitive impairment
|
||||
- Alzheimer disease
|
||||
- Sporadic subcortical arteriosclerotic encephalopathy
|
||||
- Vascular dementia
|
||||
- Frontotemporal lobar degeneration
|
||||
- ## Clinical Issues
|
||||
|
||||
|
||||
- WMHs correlate with age, silent stroke, hypertension, female sex
|
||||
- ## Diagnostic Checklist
|
||||
|
||||
|
||||
- Cannot predict cognitive function from CT/MR
|
||||
- If brain volume loss appears disproportionate to age, look for potential neurodegenerative or systemic causes
|
||||
|
||||
# TERMINOLOGY
|
||||
|
||||
- ## Definitions
|
||||
|
||||
|
||||
- ↓ overall brain volume with advancing age
|
||||
- Reflected in relative ↑ CSF spaces
|
||||
|
||||
# IMAGING
|
||||
|
||||
- ## General Features
|
||||
|
||||
|
||||
- ### Best diagnostic clue
|
||||
|
||||
|
||||
- "Successfully aging brain"
|
||||
- Thin, periventricular, high-signal rim
|
||||
- Absent/few white matter hyperintensities (WMHs)
|
||||
- Mild shrinkage of selected cerebellar regions
|
||||
- ### Location
|
||||
|
||||
|
||||
- Selective atrophy of white matter (WM) predominates, not gray matter (GM)
|
||||
- Striatum (primarily caudate nucleus, putamen)
|
||||
- ### Size
|
||||
|
||||
|
||||
- ↓ total brain volume
|
||||
- Absolute striatal size
|
||||
- Caudate ↓ linearly with age
|
||||
- Putamen remains relatively stable
|
||||
- Relative striatal size (ratio of absolute size:total brain volume)
|
||||
- Caudate remains relatively stable
|
||||
- Putamen ↑ linearly with age
|
||||
- ### Morphology
|
||||
|
||||
|
||||
- Brain tissue ↓, CSF volume ↑
|
||||
- Reflects overall WM volume loss > focal WMHs
|
||||
- Rounded appearance of dilated ventricles, sulci ↑
|
||||
- Strong correlation between WM volume and CSF volume: Measure of overall brain atrophy
|
||||
- ## CT Findings
|
||||
|
||||
|
||||
- ### NECT
|
||||
|
||||
|
||||
- Enlarged ventricles, widened cortical sulci
|
||||
- Patchy periventricular low densities
|
||||
- ± symmetrical, punctate calcifications in globi pallidi (GP)
|
||||
- ± curvilinear vascular Ca⁺⁺
|
||||
- ± punctate hippocampal Ca⁺⁺
|
||||
- ### CECT
|
||||
|
||||
|
||||
- No parenchymal enhancement
|
||||
- ## MR Findings
|
||||
|
||||
|
||||
- ### T1WI
|
||||
|
||||
|
||||
- Mild but symmetric ventricular enlargement, proportionate prominence of subarachnoid spaces
|
||||
- Mild but significant age-related shrinkage of
|
||||
- Posterior vermis (lobules 6, 7, and 8-10)
|
||||
- Cerebellar hemispheres
|
||||
- Apparent age invariance of anterior vermis, ventral pons
|
||||
- Enlarged perivascular (Virchow-Robin) spaces
|
||||
- Common in aging, considered reflection of cerebral small vessel disease
|
||||
- Isointense to CSF on all sequences
|
||||
- Conform to course of penetrating arteries
|
||||
- Round/oval/curvilinear
|
||||
- Smooth, well-defined margins
|
||||
- Bilateral, often symmetrical; usually no mass effect
|
||||
- ↑ in number, size (> 2 mm) with age
|
||||
- Can be found in most areas
|
||||
- Midbrain, hippocampi, basal ganglia (BG), & centrum semiovale
|
||||
- Tend to cluster around anterior commissure
|
||||
- Inferior 1/3 of putamen, external capsule
|
||||
- ### T2WI
|
||||
|
||||
|
||||
- Focal/confluent periventricular WMHs
|
||||
- Number/size ↑ after 50 years; ~ universal after 65 years
|
||||
- Only rough correlation with cognitive function
|
||||
- Significant overlap with dementias
|
||||
- Infarct-like T2-hyperintense lesions
|
||||
- Seen in 1/3 of asymptomatic patients > 65 years
|
||||
- 70% < 10 mm
|
||||
- Mostly in BG, thalami
|
||||
- Probably represent clinically silent lacunar infarcts
|
||||
- ### FLAIR
|
||||
|
||||
|
||||
- Smooth, thin, periventricular hyperintense rim is normal
|
||||
- Focal high signal intensity in splenium of corpus callosum
|
||||
- BG and thalamic foci
|
||||
- Perivascular spaces suppress
|
||||
- Lacunar infarcts hyperintense
|
||||
- ### T2* GRE
|
||||
|
||||
|
||||
- SWI: Increasing mineralization of BG with age
|
||||
- Normal in GP, abnormal in thalamus
|
||||
- Can see linear "waves" or conglomerate mineralization in GP
|
||||
- Putaminal hypointensity less prominent until 8th decade
|
||||
- Microbleeds are common in aging brain
|
||||
- SWI demonstrates microbleeds in 20% of patients > 60 years and in 60-70% of patients > 80 years
|
||||
- Microbleeds are relatively common in aging patients
|
||||
- Lower prevalence than in cerebral amyloid disease & Alzheimer disease
|
||||
- BG, brainstem, and cerebellar microbleeds indicative of chronic hypertensive encephalopathy
|
||||
- Lobar and cortical microbleeds typical of amyloid angiopathy
|
||||
- SWI: "Black line" in visual, motor/sensory cortex
|
||||
- Common, normal in older patients
|
||||
- ### DWI
|
||||
|
||||
|
||||
- Small but significant ↑ water diffusibility
|
||||
- ADC ↑
|
||||
- DTI: Loss of fractional anisotropy in normal-appearing WM
|
||||
- ### T1WI C+
|
||||
|
||||
|
||||
- Age-related WMHs do not enhance
|
||||
- If enhancing, consider acute/subacute lacunar infarct or metastases
|
||||
- ### MRS
|
||||
|
||||
|
||||
- Metabolite distribution varies among different brain regions
|
||||
- Choline (Cho) content ↑ with aging
|
||||
- Creatine (Cr) ↑ with aging
|
||||
- N-acetyl aspartate (NAA) ↓ in cortex, centrum semiovale, temporal lobes
|
||||
- ## Nuclear Medicine Findings
|
||||
|
||||
|
||||
- ### PET
|
||||
|
||||
|
||||
- Metabolic alterations common
|
||||
- Global, regional changes in cerebral blood flow (CBF)
|
||||
- Gradual ↓ in regional CBF of GM, WM
|
||||
- Particularly in frontal lobes
|
||||
- Age-related shift from anterior to posterior cortical metabolism
|
||||
- Putamen receives primarily posterior cortical input
|
||||
- Caudate receives relatively more anterior cortical input
|
||||
- Relative glucose metabolic rate (rGMR) measured by FDG PET
|
||||
- With age, rGMR ↑ in putamen and ↓ in caudate
|
||||
- ↓ pre-/postsynaptic dopamine markers in BG
|
||||
- Tc-99m HMPAO SPECT, Xe-133 inhalation show regional, global reduction in CBF
|
||||
- ## Imaging Recommendations
|
||||
|
||||
|
||||
- ### Best imaging tool
|
||||
|
||||
|
||||
- MR with FLAIR, DWI, T2* GRE/SWI
|
||||
|
||||
# DIFFERENTIAL DIAGNOSIS
|
||||
|
||||
- ## Mild Cognitive Impairment
|
||||
|
||||
|
||||
- Overlap with normal on standard imaging studies
|
||||
- Associated with ↓ size and number of regions of brain activation in response to memory tasks despite normal-appearing brain on conventional MR
|
||||
- Higher calculated hippocampal ADCs (not visible)
|
||||
- Subtle hypoperfusion, hypometabolism in parahippocampal regions, cingulum, thalamus
|
||||
- ↓ NAA
|
||||
- [Alzheimer Disease](/document/alzheimer-disease/f71f5cf5-b1af-4c6d-b145-b4c10eec7b58)
|
||||
- Parietal and temporal cortical atrophy
|
||||
- Striking volume loss in hippocampi, entorhinal cortex
|
||||
- Often coexisting microvascular disease, WMHs
|
||||
- Striking temporoparietal hypometabolism, hypoperfusion
|
||||
- ↓ NAA, ↑ myoinositol (mI)
|
||||
- [Sporadic Subcortical Arteriosclerotic Encephalopathy](/document/chronic-hypertensive-encephalopathy/1afc1f3f-203d-4cdf-8d49-2283cb13d6db)
|
||||
- Associated with hypertension
|
||||
- Numerous WMHs (overlap with normal)
|
||||
- Multiple lacunar infarcts
|
||||
- Lenticular nuclei, pons, thalamus, internal capsule, and caudate nuclei
|
||||
- Diffuse, confluent regions of periventricular WM involvement (leukoaraiosis)
|
||||
- [Vascular Dementia](/document/vascular-dementia/f59dab57-c511-4369-8fcc-592421a4b8d1)
|
||||
- Hyperintense lesions on T2WI and focal atrophy suggestive of chronic infarcts
|
||||
- [Frontotemporal Lobar Degeneration](/document/frontotemporal-lobar-degeneration/49510d0e-acf7-45cb-9eb1-53f8193b0b6d)
|
||||
- Asymmetric frontal, anterior temporal atrophy
|
||||
- T2 hyperintensity in frontotemporal WM
|
||||
- Dilated subarachnoid space over frontal lobes signifying atrophy
|
||||
- ↓ metabolic activity in frontotemporal cortices
|
||||
|
||||
# PATHOLOGY
|
||||
|
||||
- ## General Features
|
||||
|
||||
|
||||
- ### Etiology
|
||||
|
||||
|
||||
- Previous conception of aging: Substantial cortical neuronal loss with age
|
||||
- New: Predominant neuroanatomic changes
|
||||
- WM alterations, subcortical neuronal loss
|
||||
- Reduction in cell size > cell number
|
||||
- Neuronal dysfunction rather than loss of neurons/synapses
|
||||
- ↓ neuronal viability or function associated with accelerated membrane degradation &/or ↑ glial cell numbers
|
||||
- Loss of synapses and dendritic pruning in selected areas rather than globally
|
||||
- Some investigators consider accumulation of neurofibrillary tangles (NFTs) may be responsible for memory loss associated with aging
|
||||
- ### Genetics
|
||||
|
||||
|
||||
- Clearly affect aging of brain
|
||||
- Apolipoprotein E (*APOE*) and 6 novel risk-associated single nucleotide polymorphisms (SNPs) on chromosome 17q25 associated with brain pathology in aging
|
||||
- ## Gross Pathologic & Surgical Features
|
||||
|
||||
|
||||
- Widened sulci, proportionate large ventricles
|
||||
- Minor thinning of cortical mantle, predominant changes in subcortical WM
|
||||
- ## Microscopic Features
|
||||
|
||||
|
||||
- Degeneration of neurons and oligodendrocytes
|
||||
- ↓ myelinated fibers in subcortical WM
|
||||
- ↑ extracellular space, gliosis
|
||||
- Iron deposition in GP, putamen
|
||||
- WM capillaries lose pericytes, have thinner endothelium
|
||||
- Dilated perivascular spaces of Virchow-Robin
|
||||
- Extension of subarachnoid space that accompanies penetrating vessels into brain to level of capillaries
|
||||
- Senile plaques
|
||||
- Extracellular amyloid deposits in cerebral GM
|
||||
- Lewy bodies
|
||||
- Intraneuronal clumps of α-synuclein and ubiquitin proteins
|
||||
- Found in 5-10% of cognitively intact individuals
|
||||
- NFTs
|
||||
- Tau phosphorylation, mitochondrial dysfunction may precede full NFT formation
|
||||
- NFTs appear in small numbers in entorhinal and transentorhinal cortices early in aging (patients ~ 60 years)
|
||||
- NFTs may induce neural dysfunction, destruction of synapses, and, eventually, neuronal death
|
||||
|
||||
# CLINICAL ISSUES
|
||||
|
||||
- ## Presentation
|
||||
|
||||
|
||||
- ### Most common signs/symptoms
|
||||
|
||||
|
||||
- Normal cognitive function
|
||||
- Mild cognitive impairment correlates with ↑ risk of Alzheimer disease
|
||||
- ## Demographics
|
||||
|
||||
|
||||
- ### Age
|
||||
|
||||
|
||||
- > 60 years
|
||||
- ### Sex
|
||||
|
||||
|
||||
- Differences in striatal size
|
||||
- Relatively constant across lifespan in men
|
||||
- Variable across lifespan in women: Smaller in women aged 50-70 years than in men
|
||||
- Differences in rGMR
|
||||
- Caudate: Higher rGMR in women than men
|
||||
- Putamen: Equal rGMR in women and men
|
||||
- Greater dopamine transporters in caudate in women
|
||||
- ### Epidemiology
|
||||
|
||||
|
||||
- WMHs correlate with age, silent stroke, hypertension, female sex
|
||||
- ## Natural History & Prognosis
|
||||
|
||||
|
||||
- Parenchymal volume ↓, CSF spaces ↑ progressively
|
||||
- WMHs progressively ↑ with age
|
||||
|
||||
# DIAGNOSTIC CHECKLIST
|
||||
|
||||
- ## Consider
|
||||
|
||||
|
||||
- Striatum may mediate age-associated cognitive decline
|
||||
- ↓ volume, functional activity with age
|
||||
- ## Image Interpretation Pearls
|
||||
|
||||
|
||||
- Broad spectrum of "normal" on imaging in elderly
|
||||
- Cannot predict cognitive function from CT/MR
|
||||
- If brain volume loss appears disproportionate to age, look for potential neurodegenerative or systemic causes
|
||||
|
||||
a71a0c8f-d105-4815-9edf-3fc113d5acc4
|
||||
Reference in New Issue
Block a user